Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Death and MEN1[original query] |
|---|
| The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics (São Paulo, Brazil) 2007 Aug 62 (4): 465-76. Lourenço Delmar Muniz, Toledo Rodrigo Almeida, Coutinho Flavia Lima, Margarido Leontina Conceição, Siqueira Sheila Aparecida Coelho, dos Santos Marcelo Augusto Cortina Gonçalves, Montenegro Fabio Luiz de Menezes, Machado Marcel Cerqueira Cesar, Toledo Sergio Pereira Almei |
| Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clinical endocrinology 2009 Apr 70 (4): 575-81. Pieterman C R C, Schreinemakers J M J, Koppeschaar H P F, Vriens M R, Rinkes I H M Borel, Zonnenberg B A, van der Luijt R B, Valk G |
| Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers. Clinical endocrinology 2012 Jan 76 (1): 67-71. van Wijk J P H, Dreijerink K M A, Pieterman C R C, Lips C J M, Zelissen P M J, Valk G |
| DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, N.Y.) 2011 1 331 (6021): 1199-203. Jiao Yuchen, Shi Chanjuan, Edil Barish H, de Wilde Roeland F, Klimstra David S, Maitra Anirban, Schulick Richard D, Tang Laura H, Wolfgang Christopher L, Choti Michael A, Velculescu Victor E, Diaz Luis A, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickol |
| Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study. Human molecular genetics 2013 Jan . Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre O, Castermans E, Ruszniewski P, Le Bras M, Delemer B, Bouchard P, Beckers A, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P |
| Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. The Journal of clinical endocrinology and metabolism 2014 Nov 99 (11): E2387-91. Bartsch Detlef K, Slater Emily P, Albers Max, Knoop Richard, Chaloupka Brunhilde, Lopez Caroline L, Fendrich Volker, Kann Peter H, Waldmann Je |
| Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study. European journal of endocrinology / European Federation of Endocrine Societies 2015 Sep . Thevenon Julien, Bourredjem Abderrahmane, Faivre Laurence, Bauters Catherine, Calender Alain, Lebras Maelle, Giraud Sophie, Niccoli Patricia, Odou Marie-Françoise, Borson-Chazot Francoise, Barlier Anne, Lombard-Bohas Catherine, Clauser Eric, Tabarin Antoine, Pasmant Eric, Chabre Olivier, Castermans Emilie, Ruszniewski Philippe, Bertherat Jerôme, Delemer Brigitte, Christin-Maitre Sophie, Beckers Albert, Guilhem Isabelle, Rohmer Vincent, Goichot Bernard, Caron Philippe, Baudin Eric, Chanson Philippe, Groussin Lionel, Du Boullay Helene, Weryha Georges, Lecomte Pierre, Schillo Franck, Bihan Helene, Archambeaud Francoise, Kerlan Veronique, Bourcigaux Nathalie, Kuhn Jean-Marc, Vergès Bruno, Rodier Michel, Renard Michel, Sadoul Jean Louis, Binquet Christine, Goudet Pier |
| Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 2018 2 154 (8): 2060-2063.e8. Roy Somak, LaFramboise William A, Liu Ta-Chiang, Cao Dengfeng, Luvison Alyssa, Miller Caitlyn, Lyons Maureen A, O'Sullivan Roderick J, Zureikat Amer H, Hogg Melissa E, Tsung Allan, Lee Kenneth K, Bahary Nathan, Brand Randall E, Chennat Jennifer S, Fasanella Kenneth E, McGrath Kevin, Nikiforova Marina N, Papachristou Georgios I, Slivka Adam, Zeh Herbert J, Singhi Aatur |
| DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression. Journal of vascular and interventional radiology : JVIR 2018 11 29 (11): 1519-1526. Ziv Etay, Rice Samuel L, Filtes John, Yarmohammadi Hooman, Boas F Edward, Erinjeri Joseph P, Petre Elena Nadia, Brody Lynn A, Brown Karen T, Covey Anne M, Getrajdman George I, Maybody Majid, Raj Nitya, Sofocleous Constantinos T, Solomon Stephen B, Reidy-Lagunes Dia |
| High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype. Cancers 2020 7 12 (7): . Machlowska Julita, Kapusta Przemys?aw, Baj Jacek, Morsink Folkert H M, Wo?kow Pawe?, Maciejewski Ryszard, Offerhaus G Johan A, Sitarz Robe |
| Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes. Cardiovascular diabetology 2022 10 21 (1): 206. Sanchez Manuel, Kannengiesser Caroline, Hoang Sophie, Potier Louis, Fumeron Frédéric, Venteclef Nicolas, Scheen André, Gautier Jean-François, Hadjadj Samy, Marre Michel, Roussel Ronan, Mohammedi Kamel, Velho Gilber |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: